Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0JL3O
|
||||
Former ID |
DNC010649
|
||||
Drug Name |
NICARBAZIN
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530469] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H18N6O6
|
||||
Canonical SMILES |
CC1=CC(=NC(=O)N1)C.C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)[N+]<br />(=O)[O-])[N+](=O)[O-]
|
||||
InChI |
1S/C13H10N4O5.C6H8N2O/c18-13(14-9-1-5-11(6-2-9)16(19)20)15-10-3-7-12(8-4-10)17(21)22;1-4-3-5(2)8-6(9)7-4/h1-8H,(H2,14,15,18);3H,1-2H3,(H,7,8,9)
|
||||
InChIKey |
UKHWDRMMMYWSFL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530469] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.